ARCHIVES

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

Concept Approval: NCI To Solicit “White Papers” For Technology Development Ideas

July 3, 1998

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

October 11, 2002

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000

FDA Official Says Acceptance of PFS “Brings Us In Line With Our European Colleagues.”

July 21, 2006